The PrEP Costing Guidelines provide a framework for estimating the cost of providing pre-exposure prophylaxis (PrEP), which is the use of antiretroviral (ARV) drugs for preventing the acquisition of HIV infection. They are intended to provide a PrEP-specific resource for costing that could be accessible to individuals tasked with collecting, evaluating, and utilizing cost data, and who may have differing levels of familiarity with economics.
Matching Supply with Demand: Scaling Up Voluntary Medical Male Circumcision in Tanzania and Zimbabwe
In order to improve voluntary medical male circumcision (VMMC) service uptake and target demand creation activities more effectively, clients currently accessing and receiving VMMC services should be better characterized by their demographic, socioeconomic, and sexual risk behaviors. This case study of VMMC programs in the Iringa Region of Tanzania and Zimbabwe describes both the age distribution of clients accessing different VMMC services in both areas and the demand creation and supply side activities that country programs have implemented to increase service uptake by target clients.
Given the evidence of the effectiveness of VMMC in preventing the spread of HIV, the Government of Tanzania has adopted the medical practice as a prevention strategy. To plan for the most efficient and effective scale-up of services, it is useful to determine the costs and impacts of VMMC scale-up on the number of infections averted. This study therefore aimed to estimate the unit cost per VMMC across three different service delivery models, to help policymakers determine the costs and impacts of various options for scaling up VMMC services in the country.
Cost Analysis of the Zimbabwe National Strategic Plan for Eliminating New HIV Infections in Children and Keeping Mothers Alive: 2011-2015
The USAID |Health Policy Initiative Costing Task Order prepared a cost analysis of Zimbabwe's 2011- 2015 National Strategic Plan for Eliminating New HIV Infections in Children and Keeping Mother Alive (EMTCT strategic plan). The purpose of this costing was to:
The World Health Organization (WHO) reports that antiretroviral therapy (ART) is now available to approximately 37 percent of individuals living in sub-Saharan Africa who require it . This increase in access to treatment is evidence of impressive scale-up over the past decade. However, much works remains to be done to achieve the goal of universal access. Although providing universal access to ART and mitigating the impact of the HIV epidemic is central to local government planning, many lack sufficient capacity to develop and manage their national strategic responses.